Csequence Insights
Stay Informed and Educated with Csequence’s Blog
Raelina Krikston: Creative Intelligence for the Cannabis Market
Raelina Krikston uses her talents to create educational material for consumers. Her understanding of the changing climate within the cannabis industry makes her a key visionary on the Csequence team.
Csequence: The Must-have Video Library for those Who Want to Stay Informed on the Science and Value of Cannabis
Csequence: The Must-have Video Library for those Who Want to Stay Informed on the Science and Value of Cannabis
Understanding the Dynamics of Tobacco and Cannabis Use During Pregnancy: Insights from the PATH Study
Understanding patterns of tobacco and cannabis use during pregnancy is crucial for safeguarding maternal and fetal health. The PATH study provides valuable insights into the prevalence of co-use before, during, and after pregnancy, highlighting the need for targeted interventions to support pregnant women in reducing substance use and protecting against adverse outcomes.
FDA to reschedule marijuana according to the Associated Press
According to Associated Press this morning the FDA will move to reclassify marijuana from a Schedule I to a Schedule III drug. Schedule I drugs have a high potential for abuse and no accepted medical use, while Schedule III drugs have a lower potential for abuse and accepted medical uses. The FDA’s plans were confirmed by five sources who spoke on condition of anonymity, but as of April 30 the FDA has made no official comment. The full impact of this change to consumers, retailers, regulators, states, and those serving prison sentences for possession in currently unknown.
Understanding the Neurocognitive Effects of CannEpil: Implications for Medicinal Cannabis Use
This article is important as it provides valuable insights into the acute neurocognitive effects of CannEpil, a medicinal cannabis oil, shedding light on its potential therapeutic benefits and safety profile in treating various medical conditions.
Americans continue to embrace cannabis and an improved outlook for hemp growers
All the news this week points to changing attitudes toward cannabis at both the federal and state level. Cannabis seems to be one thing Americans can agree on and the hemp industry settles down after a wild ride the past few years.
The Link Between Cannabis Use Disorder and Perioperative Complications: What You Need to Know
This study is important because it shows that people with cannabis use disorder have a slightly higher risk of complications and even death during major surgeries compared to those without the disorder. The findings suggest that healthcare professionals should screen for cannabis use disorder before surgeries to better assess risks and plan treatments, highlighting the need to understand and address the potential impact of cannabis use on patient safety as its use becomes more common in the United States.
Border patrol, states’ rights, and stormy seas for hemp retailers
Two stories today from Marijuana Moment as state and federal officials lock horns over legalization and states’ rights. Hemp retailers face stormy waters, with calls for more regulation and evidence of inaccurate labeling.
The Complex Relationship Between Cannabis Use and Cardiovascular Health
Cannabis, once considered a recreational substance with minimal health risks, has undergone a transformative shift in public perception and usage patterns. With the increasing prevalence of cannabis use across the United States, concerns regarding its potential health implications, particularly on cardiovascular health, have come to the forefront. A recent study delved into this critical issue, shedding light on the intricate association between cannabis use and cardiovascular outcomes among diverse segments of the population. Here, we dissect the findings of this study and explore the implications for individuals, healthcare professionals, and policymakers.
Policy makers and the public at odds. Implementing legalization here and abroad. Perspectives on clinical research.
More signals that DC policy makers are out of sync with the public, as the House wrangles the marijuana banking bill. The state of Massachusetts deals with the reality of legalization and so does Germany. One study shows that marijuana use doesn’t pose a significant risk in organ donation and another suggests significant increased risk of heart attack and stroke among marijuana consumers. Once again highlighting the need for more clinical research on cannabis. The FDA offers perspective.
Unveiling the Shadows: Cannabis-Induced Psychosis and the Rising Concerns
This article is crucial as it sheds light on the increasingly common yet often overlooked risk of cannabis-induced psychosis, exemplified by the alarming case of Bryn Spejcher. By presenting scientific evidence and real-life incidents, it underscores the need for informed discussions and heightened awareness about the potential mental health consequences associated with marijuana use, particularly in the context of the evolving landscape of cannabis legalization.
Legislative Progress and Scientific Caution
A mixed bag this week, as the Fed and states inches closer to legalization researchers signal concerns on the safety of cannabis use